Back to ACRS
GOLDMAN SACHS GROUP INC → ACRS
GOLDMAN SACHS GROUP INC ACRS Position History
Aclaris Therapeutics, Inc. • Healthcare
Quarters held
20
Latest value
$74K
Q3 2026
Peak value
$4.4M
First seen
Q2 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2025 | $105K |
| Q2 2025 | $118K |
| Q3 2025 | $1M |
| Q3 2025 | $730K |
| Q3 2025 | $38K |
| Q4 2025 | $54K |
| Q4 2025 | $1.5M |
| Q4 2025 | $318K |
| Q4 2025 | $318K |
| Q4 2025 | $1.5M |
| Q4 2025 | $54K |
| Q1 2026 | $550K |
| Q1 2026 | $1.6M |
| Q1 2026 | $53K |
| Q2 2026 | $1.5M |
| Q2 2026 | $1.6M |
| Q2 2026 | $75K |
| Q3 2026 | $4.4M |
| Q3 2026 | $1.8M |
| Q3 2026 | $74K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $74K | 14.1K | — | — |
| Q3 2026 | $1.8M | 343.1K | — | — |
| Q3 2026 | $4.4M | 836.7K | — | — |
| Q2 2026 | $75K | 14.2K | — | — |
| Q2 2026 | $1.6M | 302.7K | — | — |
| Q2 2026 | $1.5M | 292.3K | — | — |
| Q1 2026 | $53K | 14.2K | — | — |
| Q1 2026 | $1.6M | 427.8K | — | — |
| Q1 2026 | $550K | 146.7K | — | — |
| Q4 2025 | $54K | 17.8K | — | — |
| Q4 2025 | $1.5M | 509.1K | — | — |
| Q4 2025 | $318K | 105.6K | — | — |
| Q4 2025 | $318K | 105.6K | — | — |
| Q4 2025 | $1.5M | 509.1K | — | — |
| Q4 2025 | $54K | 17.8K | — | — |
| Q3 2025 | $38K | 20.1K | — | — |
| Q3 2025 | $730K | 384.2K | — | — |
| Q3 2025 | $1M | 551.7K | — | — |
| Q2 2025 | $118K | 82.8K | — | — |
| Q2 2025 | $105K | 73.8K | — | — |